Biotech Values

[DewDiligence]

There’s a rumor making the rounds that BMY has dropped its protease-inhibitor program in HCV. Assuming for the sake of discussion that the rumor is true, I wonder if the reason for dropping the program is that BMY is planning to be acquired.